KELSEA COMBS: Open Payments
NPI 1265015317 · JACKSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 44 payments from 11 companies in 2025. Trend: 2023 $371 · 2024 $908 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $244 |
| Lilly USA, LLC | 5 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| ABBVIE INC. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $59 |
| Amgen Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| KYOWA KIRIN, INC. | 1 | $15 |
Products named: TRELEGY ELLIPTA, MOUNJARO, CAPLYTA, Kerendia, JARDIANCE, VRAYLAR, OTEZLA, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
